Shares of Lupin Ltd has risen as much as 4.5 per cent to ₹868.95 in early trade, their biggest intra-day per cent gain since Oct. 29, 2018.
Morgan Stanley has upgraded Lupin to 'overweight' from 'equal-weight' rating, and raised price target to ₹1.094 from ₹783.
Earnings concentration risk has normalised and the new product catalysts are in sight to revive earnings, says Margan Stanley.
The stock has a forward price-to-earnings of 36.84, more than double the sector average of 16.71.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.